domain of antibody B and VL domain of antibody A) on the Diabodies are the recombinant bispecific antibodies other . Diabodies are one of the smallest (BsAbs), constructed from heterogeneous single-chain recombinant BsAbs and the distance between the two antigenantibodies. Usually, diabodies have been prepared from binding sites is only 6.5 nm on average, which is less than bacterial periplasmic fraction using a co-expression vector half the distance in IgG . This compact (i.e. genes encoding two chains were tandemly located under size would be expected to contribute to rapid pharmacokinetics, the same promoter). Some diabodies, however, cannot be low immunogenicity and high tumor penetration (Wu et 
al., expressed as a soluble material owing to inclusion body 1996). formation, which limits the utilization of diabodies in
Usually, diabodies have been prepared from bacterial perivarious fields. Here we report an improved method for the plasmic fraction Helfrich et al. , construction of diabodies using a refolding system. As a 1998; Kipriyanov et al., 1998) . Some diabodies, however, model, a bispecific diabody binding to adenocarcinomacannot be expressed as a soluble material and therefore the associated antigen MUC1 and to CD3 on T cells was utilization of diabodies in various fields is limited. Here we studied. One chain consisted of a VH specific for MUC1 report a method for the construction of diabodies using a linked to a VL specific for CD3 with a short polypeptide refolding system. As a model, construction of a diabody linker (GGGGS). The second was composed of a VL specific for MUC1 linked to a VH specific for CD3.
reactive with both the adenocarcinoma-associated antigen The two hetero scFvs were independently obtained from MUC1 and the CD3 molecule on T cells (Mx3 diabody) intracellular insoluble fractions of Escherichia coli, purified, was studied. The target antigen in this work, MUC1, is mixed stoichiometrically (at an equivalent molar ratio of overexpressed in various epithelial carcinomas, such as those 1:1) and refolded. The refolded two hetero scFv has a arising in the pancreas, stomach, colon and ovarian and bile hetero-dimeric structure, with complete specificity for both ducts (Ban et al., 1989; Ioannides et al., 1993 ; Yamashita target cells [i.e. MUC1 positive cells and CD3 positive et al., 1993) . In our previous study of human bile duct lymphokine-activated killer cells with a T cell phenotype carcinoma (BDC)-grafted SCID mice, specific targeting therapy (T-LAK)]. Evaluation of the in vitro efficacy of T-LAK with consisting of i.v. administration of T-LAK cells sensitized with the diabody by growth inhibition assay of cancer cells c-BsAbs, i.e., anti-MUC1ϫanti-CD3 and anti-MUC1ϫanti-demonstrated maximum growth inhibition of cancer cells CD28, demonstrated remarkable inhibition of tumor growth to reach~98% at an effector:target ratio (E:T ratio) of (Katayose et al., 1996) . Preparation of the chemically synthe-10, almost identical with that with anti-MUC1ϫanti-CD3
sized BsAb (c-BsAb), however, is time consuming and chemically synthesized BsAbs (c-BsAbs). This is the first laborious with low yield and therefore an alternative method report of the construction of a diabody using a refolding was sought.
system.
The method reported here can be summarized as follows: Keywords: bispecific antibody/diabody/diabody-T-LAK cell/ mixing stoichiometrically two hetero scFvs that expressed in MUC1/refolding system Escherichia coli separately and purified from the intracellular insoluble fraction, followed by guanidine phase-removing Abbreviations: BsAb, bispecific antibody; scFv, single-chain dialysis and addition of L-arginine and oxidized glutathione to Fv antibody; T-LAK, lymphokine activated killer with T cell the refolding solution in the early folding stage. The diabody phenotype; c-BsAb, chemically synthesized BsAb; BDC, bile constructed could be recovered with high yield and sufficient duct carcinoma; SCID, severe combined immunodeficient; activity for both target antigens. In addition, this Mx3 diabody SEA, Staphylococcus enterotoxin A; HAMA, human antiwas able to retarget T-LAK cells to MUC1-positive cancer mouse antibody; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-cells with efficiency and specificity for MUC1 antigen in carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, growth inhibition assays of cancer cells. The method reported inner salt; BS, bacterial supernatant; PP, periplasmic; ICS, here would have potential in widening the scope of diabody intracellular soluble; ICIS, intracellular insoluble.
utilization in various fields.
35 min). The cell pellet was resuspended in 10 ml of 20 mM Tris-HCl (pH 7.5), 0.5 M sucrose, 0.1 mM EDTA, kept at room temperature for 5 min and 40 ml of cold water were added in order to induce osmotic shock. It was kept on ice for 30 min and the cell suspension was then centrifuged at 2000 g for 35 min at 4°C. The PP fraction was obtained from the supernatant. The remaining cells were resuspended in 10 ml of PBS, ultrasonicated at 200 W for 15 min and centrifuged at 4500 g for 20 min. The ICS fraction was recovered from the supernatant. The ICIS fraction was obtained by solubilizing the sonicated cell pellet with 10 ml of 6 M GuHCl-PBS and kept overnight at 4°C. 
SDS-PAGE and Western blotting
and VH and VL region genes of OKT3 as OH and OL, respectively. AmpR
Aliquots of 1 ml of culture supernatant served for analysis.
denotes the ampicillin resistance gene; c-myc, a sequence encoding an epitope recognized by 9E10 mAb; ori, origin of DNA replication; 6ϫ His, a
The total proteins in each fraction precipitated with 6%
sequence encoding six C-terminal histidine residues; pelB, signal peptide trichloroacetic acid (TCA) and 0.083% deoxycholate were sequence of bacterial pectate lyase.
subjected to SDS-PAGE as reported previously (Laemmli, 1970) , under reducing conditions, and proteins were stained with Coomassie Brilliant Blue R-250. Next, proteins in the Materials and methods gel were blotted to nitrocellulose membranes (Amersham,
Monoclonal antibodies (mAbs) and hybridoma cell lines
Little Chalfont, UK) and treated with blocking buffer consisting For the construction of the diabody, MUSE11 and OKT3 of PBS, 0.05% Tween 20 and 4% skim milk (Difco, Detroit, hybridoma cell lines were used as the sources of V region MI) at room temperature for 1 h. Thereafter, they were genes. The MUSE11 mAb (produced by Dr Hinoda, Sapporo incubated with peroxidase-conjugated anti-His tag mAb (Santa Medical University, Sapporo, Japan) (Hinoda et al., 1993) was Cruz Biotechnology, Santa Cruz, CA) followed by signal a mouse IgG 1 directed to epithelial mucin MUC1 antigen. enhancement using the ECL detection system (Amersham). OKT3 mAb was a mouse IgG 2a directed to the human CD3ε-Purification and refolding of diabody chain (Van Wauwe et al., 1980; Salmeron et al., 1991) .
From the ICIS fraction that contained the majority of OH-ML Cloning and construction of two kinds of hetero scFv and MH-OL, purification was carried out separately. After expression vectors, MH-OL and OH-ML
solubilization with 6 M GuHCl-PBS, the proteins were applied Primers for the preparation of VH and VL genes of MUSE11 to a 2 ml TALON metal affinity resin column (Clontech, Palo and OKT3 mAb were designed according to previous reports Alto, CA), followed by extensive washing with PBS, 6 M ( Hinoda et al., 1993; Arakawa et al., 1996; Asano et al. 2000) .
GuHCl and 1 mM imidazole. Thereafter, OH-ML and MHTotal RNA was isolated from hybridoma cell lines using OL were eluted with three buffer solutions made of PBS, 6 M Dynabeads oligo(dT) 25 (Dynal, Oslo, Norway) and first strand GuHCl and imidazole. The concentration of imidazole in the cDNA was prepared using a first strand cDNA synthesis kit elution buffer was sequentially increased from 1 to 10 and to (Life Sciences, St. Petersburg, FL). VH and VL regions were 500 mM. OH-ML and MH-OL eluted from the metal affinity amplified separately by PCR amplification. For their assembly, resin were diluted with 6 M GuHCl-PBS to a concentration VH and VL domains of HyHEL-10, a mAb raised against hen of 0.1 mg/ml (4 µM) prior to refolding. egg white lysozyme which contains the pSNE4 vector (Tsumoto The dialysis method was adopted for stoichiometric associet al., 1997) with a GlyGlyGlyGlySer short linker, were ation of two chains. Optimization of refolding conditions using replaced by those of MUSE11 or OKT3. VH and VL region dialysis in principle followed Tsumoto et al. (1998) . Two genes of MUSE11 were designated MH and ML and VH and chains were mixed stoichiometrically and refolded by guanid-VL region genes of OKT3 as OH and OL, respectively. One ine-removal dialysis with GuHCl-PBS with addition of Lhetero scFv were replaced with OH and ML and the other arginine (Arg) (Tsumoto et al., 1998) . In brief, the denaturant with MH and OL. Thus the hetero scFv genes, OH-ML and of the mixture of OH-ML and MH-OL (20 ml) was removed MH-OL, were constructed as shown in Figure 1 .
by guanidine-removal dialysis with GuHCl-PBS (1000 ml, In order to enhance the stability of the VH region of OKT3, pH 7.9, adjusted with NaOH). The dialysis buffers (pH 7.9) the cysteine residue in position 100A of the VH domain was used for refolding were as follows: (1) PBS containing 0.4 M replaced with serine (Kipriyanov et al., 1997 ) by Kunkel's Arg; (2) PBS containing 0.4 M Arg and 200 mM oxidizing method (Kunkel, 1985) . reagent (glutathione, oxidized form; Sigma); (3) PBS con-
Expression of OH-ML and MH-OL
taining sequentially decreased GuHCl (3, 2, 1, 0.5 and 0 M) with 0.4 M of Arg added during the final dialysis stage (i.e. The E.coli strain BL21 (DE3) transformed with pSNE4 MH-OL or OH-ML was grown at 28°C in 2ϫ YT broth supple-0.5 and 0 M GuHCl); (4) PBS containing sequentially decreased GuHCl (3, 2, 1, 0.5 and 0 M) and oxidizing reagent (glutathione, mented with 100 µg/ml ampicillin to the early stationary phase. In order to induce hetero scFv production, isopropyl-1-thio-β-oxidized form; Sigma) was introduced in 1 and 0.5 M GuHCl-PBS dialysis buffer (pH 7.9) and 0.4 M of Arg was added D-galactopyranoside (IPTG) (1 mM) was added to the culture and the cells were grown overnight at 28°C. From 200 ml of during the final dialysis stage (i.e. 0.5 and 0 M GuHCl). The refolding solution was finally dialyzed against PBS (pH 7.9) culture, four fractions, namely bacterial supernatant (BS), periplasmic (PP), intracellular soluble (ICS) and intracellular overnight, centrifuged at 4500 g for 20 min at 4°C and the supernatant was filtered with a 0.22 µM ultrafiltration meminsoluble (ICIS) fractions, were obtained. The BS fraction was obtained from the culture medium by centrifugation (2000 g, brane (Millipore, Tokyo, Japan). The ratio of the soluble proteins remaining in the supernatant to the denatured ones subjected to refolding was determined spectrophotometrically, i.e. division of OD 280 after refolding by OD 280 before refolding.
Gel-filtration chromatography
Gel-filtration chromatography was performed using a Superdex 75 column (Amersham-Pharmacia) (1.0ϫ100 cm) pre-equalized with PBS, pH 7.9. Molecular masses were calibrated with calibration proteins for the gel chromatography combithek (Boehringer Mannheim, Germany). A 1 ml volume of sample (0.2 mg/ml) was loaded at a flow-rate of 0.5 ml/min and 2.0 ml fractions were collected. overexpressed CHO cells were prepared as described previ-2 and 6, proteins in the PP fraction; 3 and 7, proteins in the ICS fraction; 4
Cell lines
ously (Asano et al., 2000) . These cell lines were cultured in and 8, proteins in the ICIS fraction; 9, HyHEL-10 scFv (scFv reactive with RPMI 1640 medium supplemented with 10% fetal bovine hen egg white lysozyme, positive control for anti-His tag mAb).
serum, 100 U/ml penicillin and 100 µg/ml streptomycin (designated the culture medium below).
as follows: percentage growth inhibition of cancer cells ϭ [1 -(A 490 of experiment -A 490 of background)/(A 490 of Preparation and stimulation of T-LAK cells
control -A 490 of background)]ϫ100. T-LAK cells were prepared from peripheral blood mononuclear cells by stimulation with solid-phase OKT3 mAb Results (10 µg/ml) and IL-2 (100 IU/ml), as reported previously
Expression of the Mx3 diabody in E.coli (Katayose et al., 1996) .
The MH-OL and OH-ML hetero scFvs were separately proFlow cytometric analysis duced using E.coli strain BL21(DE3) harboring the plasmid Cells (5ϫ10 5 ) were first incubated on ice with 100 µl of pSNE4 MH-OL or pSNE4 OH-ML. To estimate the amount diabody (100 µg/ml) for 30 min as the first Ab. After washing of expressed hetero-scFvs in the four fractions, Western blotting with PBS-0.1% NaN 3 , they were exposed to 9E10 anti-c-myc analysis was performed (Figure 2 ). Most MH-OL and OHmAb (Santa Cruz Biotechnology) as the second and then ML and especially MH-OL, was found in the intracellular FITC-conjugated anti-mouse IgG as the third Ab for 30 min fraction and only small amounts of gene products were on ice. The stained cells were analyzed by flow cytometry secreted into the periplasmic and bacterial culture supernatant (FACS Calibur, Becton Dickinson, San Jose, CA).
fractions. Considerable amounts of OH-ML could be obtained Absorption test by ammonium sulfate precipitation from PP or BS. On the other hand, preparation of MH-OL-soluble proteins was diffiFor the absorption test, 200 µl of diabody (100 µg/ml) were cult from PP or BS (data not shown). incubated with 5ϫ10 6 TFK-1 or T-LAK cells on ice for 30 min. After centrifugation, 200 µl of supernatant were collected and Purification and refolding of diabody half of each was added to TFK-1 and T-LAK cells (5ϫ10 5 cells)
To obtain diabody from insoluble fractions of OH-ML and for detection of residual antibody activity. After incubation on MH-OL, we optimized the refolding system as reported by ice for 30 min, the cells were exposed to the second (9E10 Tsumoto et al. (1998) . First, immobilized metal affinity mAb) and the third Ab (FITC-conjugated anti-mouse IgG). chromatography under denatured conditions was carried out Flow cytometric analysis was performed as described in the to purify OH-ML and MH-OL. The proteins eluted from previous section.
the affinity column were diluted with 6 M GuHCl-PBS to 0.1 mg/ml (4 µM). The diluted OH-ML and MH-OL were Growth inhibition assay of cancer cells mixed stoichiometrically before refolding, followed by dialysis Growth inhibition assays of cancer cells were performed with against the buffer. Without Arg, significant aggregation of an MTS assay kit (CellTiter 96TM aqueous non-radioactive proteins (~50% of total proteins) was observed in the final cell proliferation assay; Promega, Madison, WI) as described dialysis step, indicating that the appropriate addition of Arg is previously (Shinoda et al., 1998; Sakurai et al., 1999) . Briefly, critical for avoiding aggregation. More than 0.2 M Arg was 10 000 target cells in 100 µl of culture medium were distributed effective (data not shown). Sequential removal of GuHCl from to each well of a half-area (A/2) 96-well flat-bottomed plate the refolding solution increased the recovery of the proteins (Costar, Cambridge, MA). They were cultured overnight to and introduction of an oxidizing reagent (glutathione, oxidized allow adhesion to the plate. After removing the culture medium, form) in 1 and 0.5 M GuHCl-PBS dialysis buffer (pH 7.9) 100 µl of T-LAK cells preincubated with various concentrations minimizes the aggregation of the proteins. Little aggregation of diabody at 4°C for 30 min were distributed into each well.
of proteins was observed in the course of refolding and more After culture for 48 h at 37°C, each well was washed with than 95% of the proteins were recovered in the supernatant PBS three times. This was followed by addition of MTS-(the soluble fraction) under optimized refolding conditions. phenazine methosulfate solution (Promega) diluted with culture Determination of molecular weight of diabody medium. The plates were read on a microplate reader (BioRad Model 3550) at 490 nm after incubation for 1 h at 37°C.
Determination of the molecular weight of the diabody by gelfiltration chromatography revealed a major peak at a retention The percentage growth inhibition of cancer cells was calculated occurred and two bands, MH-OL (MW 29 300) and OH-ML (MW 29 800) could be seen, indicating that this peak contained results for reactivity are in line with the affinity of scFv or MH-OL and OH-ML. These results strongly suggest that diabody usually being lower than that of parental IgG (Kiprirefolded hetero antibody fragments associate with each other yanov et al., 1997), owing to there being one binding site per stoichiometrically, forming a diabody. On the other hand, molecule (Figure 4) . However, the diabody retains sufficient refolded OH-ML scFv or MH-OL scFv formed monomer, not MUC1 specificity for targeting, judging from the results of dimer, when refolded alone (Figure 3 ). In addition, formation growth inhibition assays with MUC1-positive and -negative of hetero-dimer was not observed when each chain refolded cell lines (Figures 6 and 7) . separately was mixed (data not shown). These results indicate It was found that MH-OL alone, OH-ML alone and a that the stoichiometric mixing of each chain before refolding mixture of each chain after refolding did not react with either is critical for construction of a diabody. Final yields of Mx3 TFK-1 or T-LAK cells (Figure 4 ), indicating that refolded diabody were about 6 mg from each 1 l of culture of OH-ML diabody showed bispecificity for the targets. and MH-OL.
Absorption test Flow cytometric analysis
In order to confirm the bivalency of the diabody, i.e. whether Binding of refolded diabody to cell lines was examined by every molecule refolded has two binding sites, an absorption flow cytometry (Figures 4 and 5) . Strong reactivities were test was performed. If the refolded diabody does not have two observed with MUC1-positive TFK-1 cells (Fig. 4) and MUC1 binding sites, some molecules specific for one target antigen overexpressed CHO cells (Fig. 5) , the specificity of which was cannot react with another target. After reaction with either almost identical with that of the parental IgG (MUSE11). It 5ϫ10 6 TFK-1 or T-LAK cells at 4°C, the supernatant did not was observed that the diabody did not react with MUC1-contain any diabody ( Table I ), indicating that one molecule negative HT17 cells (data not shown). It also reacted well reacted with both TFK-1 and T-LAK cells. This result suggests with T-LAK cells (CD3 positive) (Figure 4) , with a specificity that each molecule has both binding sites of two antibody molecules. slightly weaker than that of the parental IgG (OKT3). The whether growth inhibition of cancer cells by diabody is due to MUC-1, HT-17 cells (MUC1 negative) (Katayose et al., 1996) were used as target cells for this growth inhibition assay ( Figure 6 ). Mx3 diabody enhanced growth inhibition dosedependently against MUC1-positive TFK-1 cells, but not against MUC1-negative HT-17 cells.
TFK-1 and T-LAK cells were observed during the growth inhibition assay using a phase-contrast microscope (Figure 7) . When diabody and T-LAK cells were added to TFK-1 cells and co-cultured, they started to surround the target cells after about 2 h. TFK-1 cells surrounded and attacked by diabodymediated T-LAK cells began to detach from the bottom of the wells in the course of the cultivation. This phenomenon was not observed in the absence of the Mx3 diabody.
These results indicate that the diabody bridges the T-LAK cells with cancer cells (TFK-1), leading to growth inhibition using co-expression vector. Although a co-expression vector of Mx3 diabody has also been constructed, diabody could not
Growth inhibition of cancer cells with T-LAK cells been obtained from the bacterial supernatant (data not shown). preincubated with diabody attachment of T-LAK cells
This is because almost all of the hetero scFv, especially mediated by Mx3 diabody MH-OL, expressed in E.coli accumulates in the intracellular insoluble fractions (Figure 2 ), requiring the refolding system. In order for this diabody to inhibit the growth of cancer cells (TFK-1) with T-LAK cells, various concentrations of Mx3
Usually, a dilution method is used for refolding insoluble proteins (Rudolph and Lilie, 1996; Misawa and Kumagai, diabody preincubated with T-LAK cells were mixed with target TFK-1 cells. Depending on the concentration of diabody, the 1999). However, refolding at low protein concentration did not lead to stable hetero-dimer (i.e. diabody) formation (data not percentage growth inhibition of cancer cells increased and reached about 98% with an E:T ratio of 10:1 when the target shown), although each chain was refolded and concentrations of the polypeptide above the micromolar level were required for
